China focus: Sirio Pharma’s SEA expansion, postbiotic count standardisation, zooplankton’s nutrient potential, and more

China focus
China focus (Getty Images)

This edition explores Sirio Pharma’s latest moves in SEA, China’s push to standardise postbiotic count methods for industry growth, and the emerging role of zooplankton in cardiovascular and healthy ageing nutrition. We also cover Nuchev’s strong China sales performance and the impact of China’s new import tariffs on dairy and sugary products.

China’s Sirio Pharma beefs up SEA presence with new Thai plant, Singapore office

China’s Sirio Pharma is ramping up its presence in South East Asia (SEA), with the pending construction of a gummy production plant in Thailand and opening of an office in Singapore’s central business district.

The production site, to be built in Chonburi, Thailand, will manufacture gummies and also come with automatic packaging lines.

A potential total investment of up to US$40m has been approved for the project.

Explore related questions

Beta

China association publishes postbiotic count methods to aid sector growth

China Nutrition and Health Food Association (CNHFA) has formally published a document to help the industry determine postbiotic count in health foods in a bid to aid the sector’s growth.

The document, titled “Determination of Postbiotic Inactivated Lactic Acid Bacteria Count” is known as a “social organisation standard” or “tuanti biaozhun (团体标准)“ in Chinese.

Beyond omega 3: Zooca eyes China, taps big nutrient potential from small zooplankton species

Norwegian supplements brand Zooca said that Calanus finmarchicus, a tiny zooplankton, could meet cardiovascular and healthy ageing needs in China.

Its product, Zooca Calanus oil, is said to be a three-in-one combination of fatty acids, fatty alcohols, and high levels of naturally occurring astaxanthin.

Goat milk maker Nuchev’s new acquisition drives nearly 50% of sales

Nuchev’s goat formula milk business in China also delivered a strong performance in the first half of FY25, aided by major shopping festival Double 11 and the launch of a new product.

Sales of its Oli6 goat milk infant formula, for instance, were up 115 per cent year-on-year in Double 11 last year.

A reason for the strong growth was due to the company conducting Double 11 presales from Q1, instead of waiting until Q2.

China tariff adjustments 2025: Dairy big winner but sugary products take major hit

China is one of the world’s largest consumer markets, and any adjustments to its import and export tariffs can have immense impacts on global trade.

Its recently-announced adjustment to its import tariffs will see many dairy products benefit – but various sugary solutions are expected to take a major hit.